Healia Clinical Trials Information Database

Motivating Persons With Schizophrenia to Exercise

This study will evaluate the impact of motivational guidance to exercise on people with schizophrenia, based on their participation in a walking program.

Description

Schizophrenia is a chronic brain disorder that affects about 1% of Americans. People with schizophrenia experience extreme paranoia, often claiming that they hear voices not heard by others and that others are invading or controlling their minds with the intent to hurt them. More specific symptoms include hallucinations, delusional behaviors, disordered movements, and decreased ability to comprehend and apply information to everyday activities. The severity of these symptoms makes self-care and regular exercise difficult for people with schizophrenia. The fatality rate from diabetes, heart disease, and other obesity-related illnesses is significantly higher in people with schizophrenia. Exercise is known to reduce health problems associated with obesity, yet few studies have encouraged exercise as a treatment method for improving the health of those with schizophrenia. Furthermore, the long-term physical and mental effects of consistent exercise on people with schizophrenia are not well-known. This study will evaluate the impact of motivational guidance to exercise on people with schizophrenia, based on their attendance, persistence, and compliance to a walking program.

Participants in this study will be randomly assigned to one of two groups. Both groups will continue their regular medications and treatments throughout the study. Upon entry, members of both groups will complete the same two forms concerning attitudes toward exercise. Group 1 participants will attend weekly 1-hour exercise information sessions for 4 weeks. Group 2 participants will attend weekly 1-hour general health information sessions for the same 4 weeks. Participants of both groups will then take part in identical 16-week walking programs. The walking program will consist of three 30- to 50-minute walks per week, including 10 minutes of warm up and 10 minutes of cool down stretching. All participants will gradually increase their walking time from 5 minutes to 30 minutes during the program. At the completion of the walking programs, participants of both groups will complete repeat forms about their attitudes toward exercise. There will be no follow-up visits for the participants.

Status: Recruiting (N/A). Started on November 1st, 2007. Ended on August 1st, 2009.

Enrollment: 80 subjects

Study Type: Interventional

Study Design:

  • Treatment
  • Randomized
  • Single Blind (Investigator)
  • Active Control
  • Parallel Assignment
  • Safety/Efficacy Study

Conditions:

Interventions:

  • Behavioral: Motivational group sessions
  • Other: Time and attention control group sessions

Eligibility

Inclusion Criteria:

  • Meets DSM-IV criteria for schizophrenia

  • Speaks English

  • Stable medication regimen

  • Able to receive medical clearance for moderate exercise

Exclusion Criteria:

  • Hospitalized within 1 year of study entry for angina, heart attack, or cardiac surgery

  • Diagnosed with congestive heart failure

  • Has a pacemaker

  • Heart rate less than 50 bpm or more than 100 bpm at rest

  • Uncontrolled hypertension

  • History of spinal or hip fracture

  • Unable to walk or move around without assistance

  • Any other medical condition, in the opinion of primary care provider, that would prevent safe participation in the study

Gender

Both

Mininum Age

22 Years

Maximum Age

N/A

Healthy Volunteers

No


Resources

Source: National Institute of Mental Health (NIMH)

Authority: United States: Federal Government

Locations

  • Helen Ross McNabb Center
    Knoxville
    Tennessee
    37917
    United States

Officials

  • Lora L. Beebe, PhD, APRN, BC (Principal Investigator, University of Tennessee)

Sponsors

  • National Institute of Mental Health (NIMH) (Lead Sponsor)

References

None.

Links

None.


Date Verified
May 1st, 2008
First Received
May 13th, 2008
Last Changed
May 13th, 2008

Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.


All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.

The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.